Frequently Asked Questions
The market value for biotech ingredient market is projected USD 81.65 billion by 2029.
The biotech ingredient market is to grow at a CAGR of 5.30% during the forecast period of 2022 to 2029.
The major players operating in the Biotech Ingredient Market are AbbVie Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Bristol-Myers Squibb Company (U.S.), Lilly (U.S.), GSK Plc (U.K.), Merck & Co (U.S.), Pfizer Inc. (U.S.), Sanofi (France), Teva Pharmaceutical Industries Ltd.(Israel), AstraZeneca (U.K.), Mylan N.V (U.S.), Novartis AG (Switzerland), BD (U.S.), bioMérieux (France), Cepheid Inc. (U.S.), Bruker (U.S.).
On the basis of product, the Biotech Ingredient Market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors.
